美国动脉瘤手术与血管内治疗后的手术量、结局与并发症(1993-2015年):二十余年实践后持续演变与稳态并存
基于美国全国住院患者样本1993至2015年数据,分析破裂与未破裂动脉瘤手术夹闭与血管内治疗的手术量、结局及并发症趋势。结果显示血管内治疗量显著增加,夹闭术治疗破裂动脉瘤减少而未破裂动脉瘤略增;蛛网膜下腔出血发生率保持稳定但严重程度上升,夹闭术后非例行出院比例更高。
要点
- 未破裂动脉瘤诊断年入院量增加近5倍,蛛网膜下腔出血量增加不足50%。
- 夹闭治疗破裂动脉瘤持续下降(1999年后APC -6.22%,p<0.001),血管内治疗逐年增加。
- 蛛网膜下腔出血发生率稳定在12/10万人年,但严重程度、患者年龄及合并症均上升。
核心结论
- 1993至2015年,破裂和未破裂动脉瘤的血管内治疗量显著增加,夹闭术治疗破裂动脉瘤减少而未破裂动脉瘤略增。
- 尽管未破裂动脉瘤诊断和治疗增加,蛛网膜下腔出血发生率保持不变。
- 破裂动脉瘤中蛛网膜下腔出血严重程度、年龄、合并症及非例行出院均随时间增加;未破裂动脉瘤治疗后例行出院自1998年以来基本不变,且夹闭术后仍较低。
研究设计与样本
- 数据来源于1993至2015年美国全国住院患者样本(National Inpatient Sample)。
- 使用ICD-9编码估算破裂和未破裂动脉瘤治疗后的年手术量、结局和并发症。
- 采用单因素和多因素分析估算并发症和结局的风险比,使用年度百分比变化(APC)评估时间趋势。
主要发现
- 未破裂动脉瘤诊断年入院量增加近5倍,而蛛网膜下腔出血量增加不足50%。
- 夹闭治疗破裂动脉瘤持续下降(1999年前APC -0.86%,p=0.69;1999年后APC -6.22%,p<0.001),夹闭治疗未破裂动脉瘤略增(APC 2.02%,p<0.001)。
- 血管内治疗在2002-2004年增至三倍,此后持续增加(未破裂动脉瘤APC 7.22%,p<0.001;破裂动脉瘤APC 5.85%,p=0.01)。
- 蛛网膜下腔出血发生率稳定在12/10万人年(APC 0.04%,p=0.83),但严重程度、患者年龄和合并症均增加(均p<0.001)。
- 夹闭术后并发症比血管内治疗更常见,但此差异在研究期间缩小,在破裂动脉瘤中较不明显。
关键数值与推荐
- 未破裂动脉瘤治疗后出院回家比例:夹闭术69.3%-79.5% vs 血管内治疗88.3%-93.3%(p<0.001),自1998年以来变化均很小(夹闭APC -0.39%,p=0.02;血管内治疗APC -0.11%,p=0.14)。
- 蛛网膜下腔出血后非例行出院随时间增加:血管内治疗APC 1.24%,夹闭术APC 1.10%;同期死亡率下降:血管内治疗APC -2.48%,夹闭术APC -1.44%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adoption of endovascular treatment (EVT) and other advances in aneurysm care have shifted practice patterns of cerebral aneurysm treatment over the past 2 decades in the US. The objective of this study was to determine whether resulting trends in volumes, outcomes, and complications have matured in general practice or continue to evolve. METHODS: Data were obtained from the National Inpatient Sample from 1993 to 2015. ICD-9 codes were used to estimate annual volumes, outcomes, and complications following treatment of ruptured and unruptured aneurysms. Univariate and multivariate analyses were used to estimate risk ratios for complications and outcomes. Trends in time were assessed utilizing annual percentage change (APC). RESULTS: The authors found a nearly 5-fold increase in annual admissions with diagnoses of unruptured aneurysms, whereas SAH volume increased less than 50%. Clipping ruptured aneurysms steadily declined (APC -0.86%, p = 0.69 until 1999, then -6.22%, p < 0.001 thereafter), whereas clipping unruptured aneurysms slightly increased (APC 2.02%, p < 0.001). EVT tripled in 2002-2004 and steadily increased thereafter (APC 7.22%, p < 0.001 and 5.85%, p = 0.01 for unruptured and ruptured aneurysms, respectively). Despite a 3-fold increase in both diagnosis and treatment of unruptured aneurysms, the incidence of SAH remained steady at 12 per 100,000 persons per year (APC 0.04%, p = 0.83). In contrast, SAH severity increased over time, as did patient age and comorbidities (all p < 0.001). SAH led to nonroutine discharge more frequently over time after both EVT and clipping (APC 1.24% and 1.10%, respectively), although mortality decreased during the same time (APC -2.48% and -1.44%, respectively). Complications were more frequent after clipping than EVT, but this differential risk diminished during the study period and was less perceptible in ruptured aneurysms. The proportion of patients discharged home after treatment of unruptured aneurysms was significantly lower (p < 0.001) after clipping (69.3%-79.5%) than EVT (88.3%-93.3%); both proportions changed minimally since 1998 (APC -0.39%, p = 0.02, and APC -0.11%, p = 0.14, respectively). CONCLUSIONS: EVT volume markedly increased for ruptured and unruptured aneurysms from 1993 to 2015, whereas clipping decreased for ruptured and slightly increased for unruptured aneurysms. The incidence of SAH remained unchanged despite increased diagnosis and treatment of unruptured aneurysms. In ruptured aneurysms, SAH severity has increased over time, as have age, comorbidities, and nonroutine discharges. In contrast, routine discharge after treatment of unruptured aneurysms remains largely unchanged since 1998 and remains lower with clipping.
引用
- Golnari P, Nazari P, Garcia RM, et al. Volumes, outcomes, and complications after surgical versus endovascular treatment of aneurysms in the United States (1993-2015): continued evolution versus steady-state after more than 2 decades of practice. J Neurosurg. 2020. PMID: 32032946. doi:10.3171/2019.12.JNS192755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。